Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVJF) Amortization of Goodwill (2016 - 2024)

Historic Amortization of Goodwill for Teva Pharmaceutical Industries (TEVJF) over the last 4 years, with Q4 2024 value amounting to $280.0 million.

  • Teva Pharmaceutical Industries' Amortization of Goodwill changed N/A to $280.0 million in Q4 2024 from the same period last year, while for Dec 2025 it was $280.0 million, marking a year-over-year decrease of 7812.5%. This contributed to the annual value of $1.3 billion for FY2024, which is 8285.71% up from last year.
  • As of Q4 2024, Teva Pharmaceutical Industries' Amortization of Goodwill stood at $280.0 million.
  • In the past 5 years, Teva Pharmaceutical Industries' Amortization of Goodwill registered a high of $700.0 million during Q2 2023, and its lowest value of $280.0 million during Q4 2024.